David V Goeddel - Net Worth and Insider Trading

David V Goeddel Net Worth

The estimated net worth of David V Goeddel is at least $160 Million dollars as of 2024-05-12. David V Goeddel is the Director, 10% Owner of Tenaya Therapeutics Inc and owns about 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $97 Million. David V Goeddel is the Director, 10% Owner of NGM Biopharmaceuticals Inc and owns about 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $34 Million. David V Goeddel is also the Director, 10% Owner of RAPT Therapeutics Inc and owns about 6,777,151 shares of RAPT Therapeutics Inc (RAPT) stock worth over $29 Million. Details can be seen in David V Goeddel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David V Goeddel has not made any transactions after 2024-02-12 and currently still holds the listed stock(s).

Transaction Summary of David V Goeddel

To

David V Goeddel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David V Goeddel owns 11 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .

Click here to see the complete history of David V Goeddel’s form 4 insider trades.

Insider Ownership Summary of David V Goeddel

Ticker Comapny Transaction Date Type of Owner
RAPT RAPT Therapeutics Inc 2021-08-18 10 percent owner
NGM NGM Biopharmaceuticals Inc 2023-11-16 director & 10 percent owner
NRIX Nurix Therapeutics Inc 2021-05-07 10 percent owner
2020-11-16 10 percent owner
2021-11-12 10 percent owner
2020-03-19 10 percent owner & other: Managing Partner
2019-04-02 10 percent owner & other: Managing Partner
2018-09-27 other: Managing Partner
2018-03-14 10 percent owner
2021-08-25 10 percent owner
2024-02-12 director & 10 percent owner

David V Goeddel Latest Holdings Summary

David V Goeddel currently owns a total of 3 stocks. Among these stocks, David V Goeddel owns 22,999,565 shares of Tenaya Therapeutics Inc (TNYA) as of February 12, 2024, with a value of $97 Million and a weighting of 60.44%. David V Goeddel owns 22,008,593 shares of NGM Biopharmaceuticals Inc (NGM) as of November 16, 2023, with a value of $34 Million and a weighting of 21.2%. David V Goeddel also owns 6,777,151 shares of RAPT Therapeutics Inc (RAPT) as of November 4, 2019, with a value of $29 Million and a weighting of 18.36%.

Latest Holdings of David V Goeddel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNYA Tenaya Therapeutics Inc 2024-02-12 22,999,565 4.20 96,598,173
NGM NGM Biopharmaceuticals Inc 2023-11-16 22,008,593 1.54 33,893,233
RAPT RAPT Therapeutics Inc 2019-11-04 6,777,151 4.33 29,345,064

Holding Weightings of David V Goeddel


David V Goeddel Form 4 Trading Tracker

According to the SEC Form 4 filings, David V Goeddel has made a total of 6 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Tenaya Therapeutics Inc is the acquisition of 2,222,222 shares on February 12, 2024, which cost David V Goeddel around $10 Million.

According to the SEC Form 4 filings, David V Goeddel has made a total of 51 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 51 buys and 0 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 26,811 shares on November 16, 2023, which cost David V Goeddel around $18,232.

According to the SEC Form 4 filings, David V Goeddel has made a total of 1 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RAPT Therapeutics Inc is the acquisition of 625,000 shares on November 4, 2019, which cost David V Goeddel around $8 Million.

Insider Trading History of David V Goeddel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David V Goeddel Trading Performance

GuruFocus tracks the stock performance after each of David V Goeddel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David V Goeddel is 26.42%. GuruFocus also compares David V Goeddel's trading performance to market benchmark return within the same time period. The performance of stocks bought by David V Goeddel within 3 months outperforms 39 times out of 61 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David V Goeddel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David V Goeddel

Average Return

Average return per transaction

Outperforming Transactions

36 out of 59 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.59
Relative Return to S&P 500(%) 11.26

David V Goeddel Ownership Network

Ownership Network List of David V Goeddel

No Data

Ownership Network Relation of David V Goeddel


David V Goeddel Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

David V Goeddel is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc (RAPT) Insider Trades Summary

Over the past 18 months, David V Goeddel made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 39,000 shares made by William Ho , a net sale of 1,640 shares made by Dirk G. Brockstedt , and a net purchase of 5,000 shares made by Wendye Robbins .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,640 shares of RAPT Therapeutics Inc (RAPT) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 35,640 shares.

RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RAPT Therapeutics Inc Insider Transactions

No Available Data

David V Goeddel Mailing Address

Above is the net worth, insider trading, and ownership report for David V Goeddel. You might contact David V Goeddel via mailing address: C/o Column Group Lp, 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on David V Goeddel

No discussions yet.